Rapid tests reduce the burden of tuberculosis in Azerbaijan prisons: special emphasis on rifampicin-resistance.

dc.contributor.authorElmira Gurbanova
dc.contributor.authorRafail Mehdiyev
dc.contributor.authorKai Blöndal
dc.contributor.authorAlan Altraja
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T15:52:04Z
dc.date.available2026-03-22T15:52:04Z
dc.date.issued2019
dc.descriptionCitaciones: 3
dc.description.abstractIntroduction of rapid tests into the screening lead to decline in the burden of TB and RIF-resistance, and improved outcomes of treatment with first-line drugs in prisons.
dc.identifier.urihttps://pubmed.ncbi.nlm.nih.gov/30908566
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/54880
dc.language.isoen
dc.publisherNational Institutes of Health
dc.relation.ispartofPubMed
dc.sourceMinistry of Healthcare
dc.subjectMedicine
dc.subjectTuberculosis
dc.subjectConfidence interval
dc.subjectRifampicin
dc.subjectInternal medicine
dc.subjectIncidence (geometry)
dc.subjectOdds ratio
dc.subjectCase finding
dc.titleRapid tests reduce the burden of tuberculosis in Azerbaijan prisons: special emphasis on rifampicin-resistance.
dc.typearticle

Files